Literature DB >> 25677368

Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.

Thamara E Osinga1, Esther Korpershoek, Ronald R de Krijger, Michiel N Kerstens, Robin P F Dullaart, Ido P Kema, Bernard F A M van der Laan, Anouk N A van der Horst-Schrivers, Thera P Links.   

Abstract

BACKGROUND/AIM: Increased dopamine production may be a feature of head and neck paraganglioma (HNPGL). 18F-fluorodihydroxyphenylalanine positron emission tomography scintigraphy has a high sensitivity for detecting HNPGLs. These observations strongly suggest that HNPGLs have the capacity for L-3,4-dihydroxyphenylalanine uptake and conversion towards dopamine. Therefore, our aim was to demonstrate the presence of catecholamine-synthesizing enzymes, i.e. tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC) and dopamine β-hydroxylase (DBH) in HNPGL tissue.
METHODS: A single-center study was performed among patients who underwent surgery for HNPGL at a single university referral center between 1994 and 2012. HNPGL tissue was immunohistochemically stained for TH, AADC and DBH. Data on paraganglioma-associated germline mutations, preoperative biochemical phenotype and imaging studies were retrieved. Catecholamine excess was defined as preoperative plasma and/or urinary levels of metanephrine, normetanephrine or 3-methoxytyramine above the upper reference limit.
RESULTS: Nineteen HNPGLs from 18 patients were evaluated. All tumor tissues (100%) stained positive for AADC, 6 (32%) for TH and 2 (11%) for DBH. Of 3 HNPGLs staining positive for DBH, 2 were also positive for AADC and TH. Catecholamine excess was only present in 1 patient (5%). The HNPGLs of this single patient only showed positive staining for AADC.
CONCLUSIONS: Catecholamine-synthesizing enzymes, in particular AADC, are expressed in the majority of HNPGL tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25677368     DOI: 10.1159/000377703

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

Review 1.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

Review 2.  What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

Authors:  Thomas G Papathomas; Diederik P D Suurd; Alfred K Lam; Ronald R de Krijger; Karel Pacak; Arthur S Tischler; Menno R Vriens
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

3.  Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma.

Authors:  Sachiko Konosu-Fukaya; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Yayoi Aoyama; Fumitoshi Satoh; Fumiyoshi Fujishima; Hironobu Sasano; Yasuhiro Nakamura
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

Review 4.  Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.

Authors:  Ozgur Mete; Sylvia L Asa; Anthony J Gill; Noriko Kimura; Ronald R de Krijger; Arthur Tischler
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

5.  Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas.

Authors:  Noriko Kimura; Kiyoto Shiga; Ken-Ichi Kaneko; Yutaka Oki; Chiho Sugisawa; Jun Saito; Seiich Tawara; Hiroshi Akahori; Susumu Sogabe; Takafumi Yamashita; Kazuhiro Takekoshi; Mitsuhide Naruse; Takayuki Katabami
Journal:  Endocr Pathol       Date:  2021-11-06       Impact factor: 3.943

Review 6.  Immunohistochemical Biomarkers in Pituitary Pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 7.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

Review 8.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 9.  Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.

Authors:  Lester D R Thompson; Anthony J Gill; Sylvia L Asa; Roderick J Clifton-Bligh; Ronald R de Krijger; Noriko Kimura; Paul Komminoth; Ernest E Lack; Jacques W M Lenders; Ricardo V Lloyd; Thomas G Papathomas; Peter M Sadow; Arthur S Tischler
Journal:  Hum Pathol       Date:  2020-05-11       Impact factor: 3.466

10.  Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.

Authors:  Divya Mamilla; Irena Manukyan; Patricia A Fetsch; Karel Pacak; Markku Miettinen
Journal:  Hum Pathol       Date:  2020-07-12       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.